Trial Profile
Multicenter Center of Prospective Study of Combination Chemotherapy with Cetuximab In metastatic Colorectal Cancer
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Dec 2015 Status changed from recruiting to discontinued, according to University Hospital Medical Information Network - Japan record.
- 04 May 2015 New trial record